Optiscan Imaging Limited is a proprietor of patents which enable a confocal microscope to be miniaturized to the point where a confocal endomicroscope is made possible.  The process enables living tissue to be examined non-invasively at a cellular level, opening up the possibilities for non-invasive disease monitoring and diagnosis.

Investor Presentation

Optiscan Initiates Head & Neck Cancer Imaging Study

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Optiscan Imaging (OIL AU)

Investor Presentation

Optiscan Initiates Head & Neck Cancer Imaging Study

OIL Investor Webinar Invite

OIL Results of Annual General Meeting

OIL 2025 AGM Presentation

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)